Post hoc exploratory analysis of the effect of foslevodopa/foscarbidopa continuous subcutaneous infusion on nocturia in patients with Parkinson’s disease

Introduction: Parkinson’s disease (PD) non-motor symptom burden, including nocturia and sleep disturbances, worsens with disease progression. Continuous dopaminergic drug delivery with nocturnal infusion in PD demonstrated improvements in sleep and nocturia. Foslevodopa/foscarbidopa (LDp/CDp) provid...

Полное описание

Библиографические подробности

Главные авторы:	K. Ray Chaudhuri, Manon Bouchard, Eric Freire-Alvarez, Rajesh Pahwa, Lars Bergmann, Resmi Gupta, Pavnit Kukreja, Megha B. Shah, Stuart H. Isaacson
Формат:	Artigo
Язык:	Inglês
Опубликовано:	Elsevier 2025-01-01
Серии:	Clinical Parkinsonism & Related Disorders
Предметы:	Parkinson’s disease Nocturia Subcutaneous infusion Foslevodopa Foscarbidopa
Online-ссылка:	http://www.sciencedirect.com/science/article/pii/S2590112525000349
Метки:	Добавить метку Нет меток, Требуется 1-ая метка записи!